254 related articles for article (PubMed ID: 11729030)
21. Double-blind donepezil-placebo crossover augmentation study of atypical antipsychotics in chronic, stable schizophrenia: a pilot study.
Risch SC; Horner MD; McGurk SR; Palecko S; Markowitz JS; Nahas Z; DeVane CL
Schizophr Res; 2007 Jul; 93(1-3):131-5. PubMed ID: 17391930
[TBL] [Abstract][Full Text] [Related]
22. Placebo-controlled trial of glycine added to clozapine in schizophrenia.
Evins AE; Fitzgerald SM; Wine L; Rosselli R; Goff DC
Am J Psychiatry; 2000 May; 157(5):826-8. PubMed ID: 10784481
[TBL] [Abstract][Full Text] [Related]
23. Modafinil improves antipsychotic-induced parkinsonism but not excessive daytime sleepiness, psychiatric symptoms or cognition in schizophrenia and schizoaffective disorder: a randomized, double-blind, placebo-controlled study.
Lohr JB; Liu L; Caligiuri MP; Kash TP; May TA; Murphy JD; Ancoli-Israel S
Schizophr Res; 2013 Oct; 150(1):289-96. PubMed ID: 23938173
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of iloperidone in the short-term treatment of schizophrenia: a post hoc analysis of pooled patient data from four phase III, placebo- and active-controlled trials.
Citrome L; Meng X; Hochfeld M; Stahl SM
Hum Psychopharmacol; 2012 Jan; 27(1):24-32. PubMed ID: 22161738
[TBL] [Abstract][Full Text] [Related]
25. Randomized, double-blind 6-month comparison of olanzapine and quetiapine in patients with schizophrenia or schizoaffective disorder with prominent negative symptoms and poor functioning.
Kinon BJ; Noordsy DL; Liu-Seifert H; Gulliver AH; Ascher-Svanum H; Kollack-Walker S
J Clin Psychopharmacol; 2006 Oct; 26(5):453-61. PubMed ID: 16974184
[TBL] [Abstract][Full Text] [Related]
26. Vitamin B6 as add-on treatment in chronic schizophrenic and schizoaffective patients: a double-blind, placebo-controlled study.
Lerner V; Miodownik C; Kaptsan A; Cohen H; Loewenthal U; Kotler M
J Clin Psychiatry; 2002 Jan; 63(1):54-8. PubMed ID: 11838627
[TBL] [Abstract][Full Text] [Related]
27. Improvement of sustained attention and visual and movement skills, but not clinical symptoms, after dehydroepiandrosterone augmentation in schizophrenia: a randomized, double-blind, placebo-controlled, crossover trial.
Ritsner MS; Gibel A; Ratner Y; Tsinovoy G; Strous RD
J Clin Psychopharmacol; 2006 Oct; 26(5):495-9. PubMed ID: 16974191
[TBL] [Abstract][Full Text] [Related]
28. Association of symptomatology and cognitive deficits to functional capacity in schizophrenia.
Perlick DA; Rosenheck RA; Kaczynski R; Bingham S; Collins J
Schizophr Res; 2008 Feb; 99(1-3):192-9. PubMed ID: 17851042
[TBL] [Abstract][Full Text] [Related]
29. Reduction in perseverative errors with adjunctive ethyl-eicosapentaenoic acid in patients with schizophrenia: Preliminary study.
Reddy R; Fleet-Michaliszyn S; Condray R; Yao JK; Keshavan MS; Reddy R
Prostaglandins Leukot Essent Fatty Acids; 2011; 84(3-4):79-83. PubMed ID: 21211955
[TBL] [Abstract][Full Text] [Related]
30. Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
Keefe RS; Seidman LJ; Christensen BK; Hamer RM; Sharma T; Sitskoorn MM; Lewine RR; Yurgelun-Todd DA; Gur RC; Tohen M; Tollefson GD; Sanger TM; Lieberman JA
Am J Psychiatry; 2004 Jun; 161(6):985-95. PubMed ID: 15169686
[TBL] [Abstract][Full Text] [Related]
31. Effects of Omega-3 in the treatment of violent schizophrenia patients.
Qiao Y; Mei Y; Han H; Liu F; Yang XM; Shao Y; Xie B; Long B
Schizophr Res; 2018 May; 195():283-285. PubMed ID: 28830741
[TBL] [Abstract][Full Text] [Related]
32. Double blind trial of adjunctive valacyclovir in individuals with schizophrenia who are seropositive for cytomegalovirus.
Dickerson FB; Stallings CR; Boronow JJ; Origoni AE; Sullens A; Yolken RH
Schizophr Res; 2009 Feb; 107(2-3):147-9. PubMed ID: 19008077
[TBL] [Abstract][Full Text] [Related]
33. Atypical antipsychotic agents in the treatment of violent patients with schizophrenia and schizoaffective disorder.
Krakowski MI; Czobor P; Citrome L; Bark N; Cooper TB
Arch Gen Psychiatry; 2006 Jun; 63(6):622-9. PubMed ID: 16754835
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
Wang X; Savage R; Borisov A; Rosenberg J; Woolwine B; Tucker M; May R; Feldman J; Nemeroff CB; Miller AH
J Psychiatr Res; 2006 Oct; 40(7):669-76. PubMed ID: 16762371
[TBL] [Abstract][Full Text] [Related]
35. A randomized placebo-controlled trial of an omega-3 fatty acid and vitamins E+C in schizophrenia.
Bentsen H; Osnes K; Refsum H; Solberg DK; Bøhmer T
Transl Psychiatry; 2013 Dec; 3(12):e335. PubMed ID: 24346133
[TBL] [Abstract][Full Text] [Related]
36. A double-blind randomized trial of mood stabilizer augmentation using lamotrigine and valproate for patients with schizophrenia who are stabilized and partially responsive.
Glick ID; Bosch J; Casey DE
J Clin Psychopharmacol; 2009 Jun; 29(3):267-71. PubMed ID: 19440081
[TBL] [Abstract][Full Text] [Related]
37. omega-3 Fatty acid treatment of women with borderline personality disorder: a double-blind, placebo-controlled pilot study.
Zanarini MC; Frankenburg FR
Am J Psychiatry; 2003 Jan; 160(1):167-9. PubMed ID: 12505817
[TBL] [Abstract][Full Text] [Related]
38. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
[TBL] [Abstract][Full Text] [Related]
39. A placebo-controlled add-on trial of the Ampakine, CX516, for cognitive deficits in schizophrenia.
Goff DC; Lamberti JS; Leon AC; Green MF; Miller AL; Patel J; Manschreck T; Freudenreich O; Johnson SA
Neuropsychopharmacology; 2008 Feb; 33(3):465-72. PubMed ID: 17487227
[TBL] [Abstract][Full Text] [Related]
40. Symptomatic remission and cognitive impairment in first-episode schizophrenia: a prospective 3-year follow-up study.
Chang WC; Ming Hui CL; Yan Wong GH; Wa Chan SK; Ming Lee EH; Hai Chen EY
J Clin Psychiatry; 2013 Nov; 74(11):e1046-53. PubMed ID: 24330905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
